MRNA R&D Expenses

Moderna · R&D Expenses

MRNA logo

MRNA R&D Expenses

Latest reported$2.88B
MRNA TTM R&D Expenses ($410.46M → $2.88B)
High-resolution chart · PNG

MRNA r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
2,876,000,000
2,925,000,000
3,132,000,000
3,479,000,000
3,815,000,000
4,336,000,000
4,507,000,000
4,791,000,000
4,814,000,000
4,741,000,000
4,845,000,000
4,650,000,000
4,310,000,000
3,872,000,000
3,295,000,000
2,732,000,000
2,433,000,000
2,144,000,000
1,991,000,000
2,101,860,000
1,925,346,000
1,656,202,000
1,370,339,000
729,002,000
504,231,000
480,871,000
496,309,000
529,215,000
518,550,000
494,533,000
454,082,000
421,480,000
406,043,000
401,073,500
410,459,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.